Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

42.59 -1.40 (-3.18%)
Streaming Delayed Price Updated: 3:29 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quidelortho Corp

< Previous 1 2 3 4 5 6 7 Next >
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... 
Via Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We've got another busy day of trading ahead of us so let's get right to it with the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Quidel (NASDAQ:QDEL) shares incre... 
Via Benzinga
Novavax Can Still Succeed, But It’s Facing High Risks
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change for NVAX stock. 
Via InvestorPlace
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Photo by Adam Nieścioruk on Unsplash 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation
The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation 
Via News Direct
Bulls Should Begin 2022 With A Win
The first trading day of the new year is seasonally very strong by a number of studies and that is reinforced by the late day weakness to end 2021. 
Via Talk Markets
Three Stocks To Buy Now For 2022
Some investors thought it would never get here, but the 
Via Talk Markets
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the... 
Via Benzinga
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ: 
Via Benzinga
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion. 
Via InvestorPlace
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, gaining 0.67% to 4,728.06. The U.S. has the... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... 
Via Benzinga
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
Stock index futures point higher as investors look to add to two days of gains. Thursday is the last trading day of the week because markets are closed on Friday in observance of... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in... 
Via Benzinga
Free COVID Tests: What Stocks Will Benefit?
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to... 
Via Benzinga
QDEL Stock Alert: What Is Going on With Quidel Today?
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result. 
Via InvestorPlace
Biotech Playbook 2021: No Help From Small Caps In Q4
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but... 
Via Talk Markets
7 Stocks to Buy to Hedge Against Omicron Variant Risks
With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD 
Via Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... 
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.